About Us

Luye Pharma Group (02186.HK), a member of Luye Life Sciences Group, is an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications.

On The Road

Luye Pharma Enters Distribution Agreement with Zuellig Pharma for Seroquel and Seroquel XR in Malaysia and Brunei, Strengthening Business Presence in ...

News

Luye Pharma Group today announced that it has entered into an agreement with Zuellig Pharma, a leading healthcare service group in Asia, under which the company grants Zuellig Pharma exclusive rights to distribute its central nervous system drugs ...

August 02,2021

Luye Pharma’s Next-Generation VMAT2 Inhibitor LY03015 Soon to Begin Clinical Trials in the U.S.

Luye Pharma Group today announced that the investigational new drug application for its in-house developed next-generation vesicular monoamine transporter 2 (VMAT2) inhibitor, LY03015, has been submitted in the U.S., with Phase I clinical ...

August 02,2021

Read More

Investors

Employee Stories

Upholding the philosophy of “Employee Development”,
Luye Pharma regards employees as the most valuable resources of the company